Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2008 (2008), Article ID 219672, 5 pages
http://dx.doi.org/10.1155/2008/219672
Research Article

Chlamydia trachomatis Serology in Women with and without Ovarian Cancer

1School of Public Health, University of Texas, Houston, TX 77030, USA
2UBC Centre for Disease Control, Vancouver, BC, Canada V5Z 4R4
3Graduate School of Public Health and Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15261, USA
4Department of Epidemiology, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY 14214, USA
5Magee-Women's Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA

Received 10 January 2008; Revised 7 August 2008; Accepted 20 October 2008

Academic Editor: Jeanne Marrazzo

Copyright © 2008 Roberta B. Ness et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. B. Ness and C. Cottreau, “Possible role of ovarian epithelial inflammation in ovarian cancer,” Journal of the National Cancer Institute, vol. 91, no. 17, pp. 1459–1467, 1999. View at Publisher · View at Google Scholar
  2. X. O. Shu, Y. T. Gao, J. M. Yuan, R. G. Ziegler, and L. A. Brinton, “Dietary factors and epithelial ovarian cancer,” British Journal of Cancer, vol. 59, no. 1, pp. 92–96, 1989. View at Google Scholar
  3. H. A. Risch and G. R. Howe, “Pelvic inflammatory disease and the risk of epithelial ovarian cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 4, no. 5, pp. 447–451, 1995. View at Google Scholar
  4. R. B. Ness, J. A. Grisso, C. Cottreau et al., “Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer,” Epidemiology, vol. 11, no. 2, pp. 111–117, 2000. View at Publisher · View at Google Scholar
  5. L. Westrom and D. Eschenbach, “Pelvic inflammatory disease,” in Sexually Transmitted Diseases, K. K. Holmes, P. G. Sparling, P.-A. Mardh et al., Eds., pp. 783–810, McGraw-Hill, New York, NY, USA, 3rd edition, 1999. View at Google Scholar
  6. C. R. Cohen and R. C. Brunham, “Pathogenesis of chlamydia induced pelvic inflammatory disease,” Sexually Transmitted Infections, vol. 75, no. 1, pp. 21–24, 1999. View at Google Scholar
  7. P.-A. Mårdh, “Tubal factor infertility, with special regard to chlamydial salpingitis,” Current Opinion in Infectious Diseases, vol. 17, no. 1, pp. 49–52, 2004. View at Publisher · View at Google Scholar
  8. I. Simms, K. Eastick, H. Mallinson et al., “Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease,” Journal of Clinical Pathology, vol. 56, no. 8, pp. 616–618, 2003. View at Publisher · View at Google Scholar
  9. J. W. Mouton, M. F. Peeters, J. H. van Rijssort-Vos, and R. P. Verkooyen, “Tubal factor pathology caused by Chlamydia trachomatis: the role of serology,” International Journal of STD & AIDS, vol. 13, supplement 2, pp. 26–29, 2002. View at Publisher · View at Google Scholar
  10. R. B. Ness, M. T. Goodman, C. Shen, and R. C. Brunham, “Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer,” Journal of Infectious Diseases, vol. 187, no. 7, pp. 1147–1152, 2003. View at Publisher · View at Google Scholar
  11. A. P. Gijsen, J. A. Land, V. J. Goossens, M. E. P. Slobbe, and C. A. Bruggeman, “Chlamydia antibody testing in screening for tubal factor subfertility: the significance of IgG antibody decline over time,” Human Reproduction, vol. 17, no. 3, pp. 699–703, 2002. View at Publisher · View at Google Scholar
  12. R. B. Ness, D. E. Soper, H. E. Richter et al., “Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study,” Sexually Transmitted Diseases, vol. 35, no. 2, pp. 129–135, 2008. View at Google Scholar